¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Alka-Seltzer Cherry Antacid and Pain Reliever Effervescen..."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
  • delayed pain
    Áö¿¬Åë°¢(òÀæÅ÷ÔÊÆ)
  • dolor =pain<³ª>
    µ¿Åë(ÔÙ÷Ô).
  • double pain
    ÀÌÁßÅë°¢(ì£ñì÷×ÊÆ).
  • dragging pain
    °ßÀÎÅë(̲ìÚ÷Ô).
  • dull pain
    µÐÅë
  • dull pain
    µÐÅë.
  • ear pain =earache
    ÀÌÅë, ±Í¾ÎÀÌ
  • elbow joint pain
    ÆÈ±Á°üÀýÅë
  • epigastric pain
    »óº¹ºÎÅë(Áõ).
  • esophagal pain
    ½ÄµµÅë
  • excruciating pain
    °ÝÅë(°ÝÅë).
  • expulsive pain
    ¹èÃâÅë(¡­÷Ô).»êºÎ¸¸Ãâ(Áø)Åë.
  • false pain
    °¡µ¿Åë ÀÓ½ÅÁßÀÇ .
  • first pain
    ÀÏÂ÷Åë(ìéó­÷Ô).
  • first stage pain
    °³±¸±âÁøÅë(ËÒϢѢòæ÷Ô).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
PRI(S) pain rating intensity score
PSR pain sensitivity range; perspective surface rendering; portal systemic resistance; proliferative sic...
PTN pain transmission neuron; pleiotrophin; posterior tibial nerve
RAP recurrent abdominal pain; regression-associated protein; renal artery pressure; resident assessment ...
RPMD rheumatic pain modulation disorder
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 16
BEP Bleomycin, etoposide, and cisplatin
BAL Blood and bronchoalveolar lavage
BALF Blood and bronchoalveolar lavage fluid
BMD Bone mineral content and density
BMC Bone mineral density and content
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pulsating pain
    ¹Úµ¿¼º µ¿Åë
    µ¿ÀǾî=
  • radiating pain
    ¹æ»êÅë
  • radicular arm pain
    ½ÉºÎ »óÁöÅë
  • radicular pain
    ô¼ö ½Å°æ ±ÙÅë
  • recurrent pain
    Àç¹ß¼º µ¿Åë
  • referred visceral pain
    ³»Àå ¿¬°üÅë
  • reflex pain
    ¹Ý»çÅë
  • renal colicky pain
    ½Å »êÅë
  • second pain
    ÀÌÂ÷ µ¿Åë, ¼Ó¹ß¼º µ¿Åë
  • second-order pain-transmitting neuron
    ÀÌÂ÷ µ¿Åë Àü´Þ ´º¿ì·±
  • secondary pain
    ¼Ó¹ß¼º ÅëÁõ, Á¦ÀÌ µ¿Åë
    µ¿ÀǾî=referred
  • self-generating pain cycle
    µ¿ÅëÀ» À¯¹ßÇÏ´Â ÀÚ¹ßÀûÀÎ ¼øÈ¯ °úÁ¤
  • self-sustaining pain
    ÀÚȰ µ¿Åë
  • sensation of pain
    Åë°¢, µ¿ÅëÀÇ °¨°¢
  • sense of pain
    Åë°¢
    ¾ÆÇÄÀ» ´À³¢´Â ÇǺΠ°¨°¢. ´Ù¸¥ ÇǺΠ°¨°¢°ú ´Ù¸¥ Á¡Àº Åë°¢À» ÀÏÀ¸Å°´Â ÀÚ±ØÀÇ Á¾·ù°¡ ƯÁ¤ÇÑ °ÍÀÌ ¾Æ´Ñ Á¡À̸ç, ¾î¶°ÇÑ Àڱصµ ±×°ÍÀÌ ¸Å¿ì °­ÇØÁ®¼­ »ýü¿¡ À¯ÇØ ÀÛ¿ëÀ» ¹ÌÄ¥ ¶§¿¡´Â ÅëÁõÀ¸·Î ´À³¢°Ô µÈ´Ù. Åë°¢ÀÇ ¼ö¿ë±â´Â üǥÀÇ ¸ðµç °÷, ü³»¿¡¼­µµ ³»ÀåÀ» Á¦¿ÜÇϰí´Â ³Î¸® ºÐÆ÷ÇÏ´Â Áö°¢ ½Å°æÀÇ ÀÚÀ¯ Á¾¸»·Î¼­ ¼öÁö»óÀ¸·Î µÇ¾î ÀÖÀ¸¸ç, Á¶Á÷ ¼Õ»ó¿¡ ÀÇÇÑ È÷½ºÅ¸¹Î»ó ¹°Áú¿¡ ÀڱصȴÙ. ÀÚÀ¯ Á¾¸»Àº ÇÇÇÏÀÇ ÃµºÎ¿Í ½ÉºÎÀÇ 2ÃþÀ¸·Î ³ª´©¾îÁö¸ç ¹Ù´Ã·Î Â´Â µíÇÑ ÅëÁõÀ̳ª Áö¼ÓµÇ´Â ¾ÆÇÄ µîÀ» ±¸º°ÇÒ ¼ö ÀÖ´Ù. °­¸ðÀÇ ³¡À» »ÏÁ·ÇÏ°Ô ÇÑ °ÍÀ¸·Î ÇǺΠǥ¸éÀ» ÀÚ±ØÇÏ¸é ¾ÆÇÄÀ» ´À³¢´Â Á¡°ú ´À³¢Áö ¾Ê´Â Á¡ÀÌ ÀÖ´Ù. ÀüÀÚ¸¦ ÅëÁ¡À̶ó Çϸç, ±× ¹Ðµµ´Â Æò±Õ 1 cm´ç 100~200À¸·Î Àüü Ç¥¸é¿¡¼­´Â 200¸¸~400¸¸ÀÌ µÇ¸ç, ÇǺΠ°¨°¢Á¡ Áß¿¡¼­´Â °¡Àå ¸¹´Ù. ±×·¯³ª ±×¸¸Å­ ´Ù¼öÀÇ Æ¯¼öÇÑ °¨°¢ ¼ö¿ë±â¸¦ ÇǺο¡¼­ º¼ ¼ö ¾ø´Â °ÍÀ¸·Î º¸¾Æ Áö°¢ ½Å°æÀÇ ÀÚÀ¯ Á¾¸»ÀÌ ¾ÆÇÄÀ» ´À³¢´Â °ÍÀ¸·Î »ý°¢µÈ´Ù. ¡¼ÅëÁõ¡½ Åë°¢ÀÌ ÀڱصÊÀ¸·Î½á ÀϾ´Â °¨°¢À¸·Î µ¿ÅëÀ̶ó°íµµ ÇÑ´Ù. ÅëÁõÀÌ ÀϾ´Â ºÎÀ§¿¡ µû¶ó À§Åë, ½ÉÀåÅë, µÎÅë, º¹Åë, ¿äÅë, ±ÙÀ°Åë, Ä¡Åë µîÀ̶ó°í Çϸç, ÅëÁõÀÇ Á¤µµ¿¡ µû¶ó¼­´Â µÐÅëÀ̳ª °ÝÅë, ¶§·Î´Â »êÅë µîÀ¸·Î ±¸º°µÇ´Â ¿Ü¿¡, ´Ù¸¥ ºÎÀ§¿¡ ¹æ»êµÇ´Â ¿¬°üÅë µîµµ ÀÖ´Ù. ½Å°æÅëÀ» ºñ·ÔÇÏ¿© ±Þ¼º ½Å°æ¿°À̳ª ³ú ¹× ô¼ö¿° µîÀÇ Ãʱ⿡´Â Åë°¢ÀÌ °ú¹ÎÇØÁö¸ç ´Ù¹ß¼º ½Å°æ¿°, ³ªº´, ô¼ö·Î, ô¼ö¿° µî¿¡¼­´Â Åë°¢ÀÌ ¹Ý´ë·Î °¨Åð ¶Ç´Â ¼Ò½ÇµÇ´Â ÀÏÀÌ ÀÖ´Ù. À̰ÍÀ» Áø´Ü¿¡ ÀÌ¿ëÇÏ´Â °æ¿ìµµ ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 16
hoof-and-mouth disease An obsolete term for foot-and-mouth disease.
(05 Mar 2000)
hormones, hormone substitutes, and hormone antagonists A collective grouping for both naturally occurring and synthetic hormones, substitutes, and antagonists.
(12 Dec 1998)
sensitivity and specificity Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person.
(12 Dec 1998)
hospital design and construction The architecture, functional design, and construction of hospitals.
(12 Dec 1998)
Hunter and Driffield curve Sensitometric curve of radiographic film, a plot of the film density versus the logarithm of the relative exposure.
Synonym: H and D curve, Hunter and Driffield curve.
(05 Mar 2000)
sexual and gender disorders Mental disorders related to sexual dysfunction, paraphillias, and gender identity disorders.
(12 Dec 1998)
sheath of Key and Retzius <anatomy> The delicate bands of connective tissue among nerve fibres.
Origin: NL, fr. Gr. Within + a sinew, nerve.
Source: Websters Dictionary
(01 Mar 1998)
hydroxymethyl and formyl transferases <enzyme> Enzymes that catalyze the transfer of hydroxymethyl or formyl groups.
Registry number: EC 2.1.2
(12 Dec 1998)
short limbs and osteopenia <radiology> Osteogenesis imperfecta, hypophosphatasia
(12 Dec 1998)
signs and symptoms Objective evidence of disease perceptible to the examining physician (sign) and subjective evidence of disease perceived by the patient (symptom).
(12 Dec 1998)
signs and symptoms, digestive Digestive system manifestations of diseases of the gastrointestinal system or of other organs.
(12 Dec 1998)
signs and symptoms, respiratory Respiratory system manifestations of diseases of the respiratory tract or of other organs.
(12 Dec 1998)
skin and connective tissue diseases A collective term for diseases of the skin and its appendages and of connective tissue.
(12 Dec 1998)
hypoplasia of the thymus and parathyroids Also known as the digeorge syndrome (dgs), this disorder is characterised by (1) low blood calcium levels (hypocalcaemia) due to underdevelopment (hypoplasia) of the parathyroid glands needed to control calcium; (2) underdevelopment (hypoplasia) of the thymus, an organ behind the breastbone in which lymphocytes mature and multiply; and (3) defects of the outflow tracts from the heart. most cases of dgs are due to a microdeletion in chromosome band 22q11.2. A small number of cases have defects in other chromosomes, notably 10p13. Named after the american paediatric endocrinologist angelo digeorge. Another name for dgs is the third and fourth pharyngeal pouch syndrome (since the faulty structures in dgs are embryologically derived from the third and fourth pharyngeal pouches).
(12 Dec 1998)
slash, burn, and poison Brutal medical slang term for surgery, radiation, and chemotherapy (as approaches to the treatment of cancer).
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 16
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 16
ÅëÇÕ°Ë»ö ¿Ï·á